focu list chang
futur
avoid leverag pharma util
scale synergi consolid initi coverag outperform rate target price
noth come guidanc increas even fx outperform rais estim
noisi stock reaction overblown littl chang guidanc reiter outperform lower estim tp
share inclus take effect tomorrow
bad news alreadi price price-to-book multi-year low upgrad outperform neutral lower estim tp
feedback idea engin
nvidia taiwan graphic confer reaffirm next foundri growth driver
revis estim downgrad neutral outperform view share reach fair level
ceo/cfo brief comment uk roadshow gener meet sharehold
host ir day expect on-going profit growth also
analyst disclosur credit suiss seek busi compani cover research
report result investor awar firm may conflict interest could affect
object report investor consid report singl factor make invest
futur
across globe continu increas gross domest product rank top polit regulatori agenda
power indic econom health perform base assumpt adequ reflect
state respect societi
avoid leverag pharma util
upgrad european pharma overweight benchmark take european global util underweight
scale synergi consolid initi coverag outperform rate target price
initi ss outperform tp believ strateg focu portfolio breadth market
leadership creat competit moat posit benefit forc shape financi servic industri also
see upsid potenti dst acquisit opportun addl accret acquisit
noth come guidanc increas even fx outperform rais estim
despit one fx-expos name coverag caus concern late core busi
drove much larger beat rais expect ep beat street tommi hilfig upsid rais
guid fx less ep benefit mean increas ep ex-fx
noisi stock reaction overblown littl chang guidanc reiter outperform lower estim tp
impress beat compstore cse/street driven improv america trend flat vs -msd
off-set europ decel cse -hsd/ldd ex-fx vs -msd amid qualiti sale initi
share inclus take effect tomorrow
a-shar inclus indic effect start june stock ad first step
fif-adjust market cap a-shar constitu ad anoth ad august second
step share altogeth weight em index
would like receiv product pleas call product market london
bad news alreadi price price-to-book multi-year low upgrad outperform neutral lower estim tp
back news government intent cancel kl-sin hsr project reduc net profit
forecast tp lower upgrad outperform believ current price
alreadi reflect expect contract inflow year price-to-book multi-year low
feedback idea engin
consider interest idea engin report cd expect key area debat continu
revolv around taxi threat pose privat hire phc
nvidia taiwan graphic confer reaffirm next foundri growth driver
taiwan gtc taipei week nvidia held taiwan leg graphic technolog confer taipei bring
togeth ecosystem hardwar softwar develop latest updat artifici intellig deep
revis estim downgrad neutral outperform view share reach fair level
revis estim lower profit outlook downgrad sysmex outperform neutral think
stronger percept share reach fair level price top
ceo/cfo brief comment uk roadshow gener meet sharehold
takeda ceo christoph weber cfo costa sarouko held brief sell-sid analyst may brief
cover shire acquisit includ discuss feedback recent uk investor visit futur ir plan
sharehold propos tabl ordinari gener meet sharehold ogm
host ir day expect on-going profit growth also
panason host ir day may compani summar result outlin busi plan
long-term strategi
headlin price previou day close unless otherwis note
would like receiv product pleas call product market london
compani mention price may
industri commerci bank china outperform tp
